The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

v3rity.com

Stage

Acquired | Acquired

About V3rity

V3rity provides specialist database security breach investigation services and develops database forensics software.In October 2011, V3rity was acquired by Accuvant. The valuation of V3rity was undisclosed. Other terms of the deal were not released.

V3rity Headquarter Location

United Kingdom

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing V3rity

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

V3rity is included in 1 Expert Collection, including Cybersecurity.

C

Cybersecurity

4,895 items

Latest V3rity News

Accuvant Buys UK Firm V3rity

Oct 11, 2011

Tweet Denver-based Accuvant , a provider of information security services, said today that it has acquired V3rity ltd., a UK-based company developing database forensics and analysis software. Accuvant said the asset deal will add database security technology and expertise to its solutions. V3rity's software is used to analyze compromised database servers. Financial terms of the buy were not disclosed. Accuvant said v3rity's founder David LItchfield, becomes Chief Security Architect at Accuvant Labs.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.